649 related articles for article (PubMed ID: 26207884)
21. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study.
Tierney AC; McMonagle J; Shaw DI; Gulseth HL; Helal O; Saris WH; Paniagua JA; Gołąbek-Leszczyñska I; Defoort C; Williams CM; Karsltröm B; Vessby B; Dembinska-Kiec A; López-Miranda J; Blaak EE; Drevon CA; Gibney MJ; Lovegrove JA; Roche HM
Int J Obes (Lond); 2011 Jun; 35(6):800-9. PubMed ID: 20938439
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome associates with left atrial dysfunction.
Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):727-734. PubMed ID: 29764718
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Three Adiposity Indexes and Cutoff Values to Predict Metabolic Syndrome Among University Students.
Correa-Bautista JE; González-Ruíz K; Vivas A; Triana-Reina HR; Martínez-Torres J; Prieto-Benavides DH; Carrillo HA; Ramos-Sepúlveda JA; Afanador-Rodríguez MI; Villa-González E; García-Hermoso A; Ramírez-Vélez R
Metab Syndr Relat Disord; 2017 Sep; 15(7):363-370. PubMed ID: 28570830
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
Santilli F; D'Ardes D; Guagnano MT; Davi G
Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
[TBL] [Abstract][Full Text] [Related]
25. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases.
Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O
Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694
[TBL] [Abstract][Full Text] [Related]
26. Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence.
Calton EK; James AP; Pannu PK; Soares MJ
Nutr Res; 2014 Jul; 34(7):559-68. PubMed ID: 25150114
[TBL] [Abstract][Full Text] [Related]
27. Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone.
Zhang X; Zhang R; Raab S; Zheng W; Wang J; Liu N; Zhu T; Xue L; Song Z; Mao J; Li K; Zhang H; Zhang Y; Han C; Ding Y; Wang H; Hou N; Liu Y; Shang S; Li C; Sebokova E; Cheng H; Huang PL
Circulation; 2011 Jul; 124(1):77-86. PubMed ID: 21690491
[TBL] [Abstract][Full Text] [Related]
28. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
[TBL] [Abstract][Full Text] [Related]
29. Central adiposity, systemic inflammation, and the metabolic syndrome.
Elks CM; Francis J
Curr Hypertens Rep; 2010 Apr; 12(2):99-104. PubMed ID: 20424938
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndrome.
Gouni-Berthold I; Berthold HK
Curr Pharm Des; 2014; 20(31):5025-38. PubMed ID: 24320031
[TBL] [Abstract][Full Text] [Related]
31. Mediterranean diet and metabolic syndrome: the evidence.
Babio N; Bulló M; Salas-Salvadó J
Public Health Nutr; 2009 Sep; 12(9A):1607-17. PubMed ID: 19689829
[TBL] [Abstract][Full Text] [Related]
32. Current Treatment Options for the Metabolic Syndrome.
Deedwania PC; Volkova N
Curr Treat Options Cardiovasc Med; 2005 May; 7(1):61-74. PubMed ID: 15913505
[TBL] [Abstract][Full Text] [Related]
33. Management of the metabolic syndrome.
Scheen AJ
Minerva Endocrinol; 2004 Jun; 29(2):31-45. PubMed ID: 15257254
[TBL] [Abstract][Full Text] [Related]
34. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM;
Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction.
Carresi C; Gliozzi M; Musolino V; Scicchitano M; Scarano F; Bosco F; Nucera S; Maiuolo J; Macrì R; Ruga S; Oppedisano F; Zito MC; Guarnieri L; Mollace R; Tavernese A; Palma E; Bombardelli E; Fini M; Mollace V
Nutrients; 2020 May; 12(5):. PubMed ID: 32455840
[TBL] [Abstract][Full Text] [Related]
36. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
Silva Figueiredo P; Inada AC; Ribeiro Fernandes M; Granja Arakaki D; Freitas KC; Avellaneda Guimarães RC; Aragão do Nascimento V; Aiko Hiane P
Molecules; 2018 Apr; 23(4):. PubMed ID: 29641459
[TBL] [Abstract][Full Text] [Related]
37. Association of metabolic syndrome and chronic kidney disease.
Scurt FG; Ganz MJ; Herzog C; Bose K; Mertens PR; Chatzikyrkou C
Obes Rev; 2024 Jan; 25(1):e13649. PubMed ID: 37783465
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effect of CLOCK gene polymorphism rs1801260 in combination with low-fat diet on insulin metabolism in the patients with metabolic syndrome.
Garcia-Rios A; Gomez-Delgado FJ; Garaulet M; Alcala-Diaz JF; Delgado-Lista FJ; Marin C; Rangel-Zuñiga OA; Rodriguez-Cantalejo F; Gomez-Luna P; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J; Perez-Martinez P
Chronobiol Int; 2014 Apr; 31(3):401-8. PubMed ID: 24328727
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
Matsuo Y; Hashizume T; Shioji S; Akasaka T
Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
[TBL] [Abstract][Full Text] [Related]
40. Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review.
Zimmermann MB; Aeberli I
Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S11-8. PubMed ID: 19079275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
